Rituximab-Induced Depletion of Anti-Pla2r Autoantibodies Predicts Response in Membranous Nephropathy

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2010111125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Circulating Anti-Pla2r Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2011English

Efficacy and Safety of Rituximab in Hepatitis-B Virus-Associated PLA2R-positive Membranous Nephropathy

Kidney International Reports
Nephrology
2018English

PLA2R Antibodies and PLA2R Glomerular Deposits in Psoriasis Patients With Membranous Nephropathy

BMC Nephrology
Nephrology
2016English

Response to Immunosuppressive Therapy in PLA2R- Associated and Non-Pla2r- Associated Idiopathic Membranous Nephropathy: A Retrospective, Multicenter Cohort Study

BMC Nephrology
Nephrology
2017English

Diagnostic Accuracy of PLA2R Autoantibodies and Glomerular Staining for the Differentiation of Idiopathic and Secondary Membranous Nephropathy: An Updated Meta-Analysis

Scientific Reports
Multidisciplinary
2015English

Non-Ischemic Cardiomyopathy After Rituximab Treatment for Membranous Nephropathy

Journal of Renal Injury Prevention
UrologyNephrology
2016English

Estimating Urinary Losses of Rituximab in Membranous Nephropathy With Nephrotic Range Proteinuria

Pathology
Forensic MedicinePathology
2020English

Detection and Monitoring PLA 2 R Autoantibodies by LIPS in Membranous Nephropathy

Journal of Immunological Methods
AllergyImmunology
2017English

Membranous Nephropathy

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy